Efficacy of mesenchymal stem cells injection for the management of knee osteoarthritis: a systematic review and meta-analysis
- 1.4k Downloads
The purpose of this study was to access the efficacy of mesenchymal stem cells (MSCs) injection in the treatment of knee osteoarthritis (OA).
Studies were identified from databases (Pubmed, Embase, Cochrane Library, Biosis Previews, ClincalTrials.gov, CBMdisc) searched to December 2014 using a battery of keywords. We included randomized controlled and controlled clinical trials of people with knee OA comparing the outcomes of pain and function for those receiving MSCs injection with those receiving no MSCs injection. Two reviewers independently selected studies, extracted relevant data and assessed study quality. Data were pooled and meta-analyses were performed.
Seven randomized controlled and controlled clinical trials, studying a total of 314 participants with a diagnosis of knee OA were included. Overall, MSCs injection has no significant effect on pain [weighted mean difference (WMD) (95 % confidence interval (CI)) [−1.33(−3.08, 0.41), P = 0.13], and tends to improve self-reported physical function [standardized mean difference (SMD) (CI) = 2.35(0.92, 3.77), P = 0.001] at the last follow-up. But results from two high quality trials (94 patients) show a positive effect of MSCs injection on pain [WMD(CI) = −0.49 (−0.79, −0.19), P = 0.001]. Heterogeneity observed between studies regarding the effect of MSCs injection on pain and function was explained by the difference of follow-up time, outcome measures, control group, the source and dose of MSCs. The quality of evidence supporting these effect estimates was rated as low.
MSCs injection could be potentially efficacious for decreasing pain and may improve physical function in patients with knee OA. The findings of this review should be confirmed using methodologically rigorous and adequately powered clinical trials.
KeywordsMesenchymal stem cells (MSCs) Osteoarthritis (OA) Knee Meta-analysis
We thank the National Science Foundation of China (Grant # 81272151) for financial support.
- 8.Bellamy N, Campbell J, Robinson V et al (2006)Intraarticular corticosteroid for treatment of osteoarthritis of the knee. Cochrane Database Sys Rev 19:CD005328Google Scholar
- 15.Jo CH, Lee YG, Shin WH et al (2014)Intra-articularinjection of mesenchymal stem cells for the treatment of osteoarthritis of the knee: a proof-of-conceptclinical trial. Stem Cells 32:1254–1266Google Scholar
- 21.Yang XH, Peng L, Liu YS et al (2013)Bone marrow mesenchymal stem cell transplantation for the treatment of temporomandibular joint osteoarthrosis. Chin J Tissue Eng Res 17:3488–3494Google Scholar
- 28.Wong KL, Lee KBL, Tai BC et al (2013)Injectable cultured bone marrow–derived mesenchymal stem cells in varus knees with cartilage defects undergoing high tibial osteotomy: a prospective, randomized controlled clinical trial with 2 years’ follow-up. Arthroscopy: J Arthrosc Relat Surg 29:2020–2028CrossRefGoogle Scholar
- 31.Orozco L, Munar A, Soler R et al. (2014)Treatment of knee osteoarthritis with allogenic mesenchymal stem cells. ClinicalTrials.gov(https://www.clinicaltrials.gov), Identifier: NCT01586312
- 32.Gan F, Tang C, Guo D et al (2014)The treatment of mesenchymal stem cell transplantation for knee osteoarthritis: a clinical observation study. Modern Diagn Treat 3512–13 (Article in Chinese)Google Scholar
- 33.Tan Y, Jiang M, Yu H et al (2013)Therapeutic effect of arthroscopy combined with autologous bone marrow stem cell grafting on knee osteoarthritis. J Tradit Chin Orthop Traumatol 35–38 (Article in Chinese)Google Scholar
- 37.Jang S-J, Kim J-D, Cha S-S(2013)Platelet-richplasma (PRP)injections as an effective treatment for early osteoarthritis. Eur J Orthop Surg Traumatol 23:573–580Google Scholar
- 39.Gobbi A, Karnatzikos G, Mahajan V et al (2012)Platelet-richplasma treatment in symptomatic patients with knee osteoarthritis: preliminary results in a group of active patients. Sports Health 4:162–172Google Scholar
- 41.Filardo G, Kon E, Buda R et al (2011)Platelet-richplasma intra-articularknee injections for the treatment of degenerative cartilage lesions and osteoarthritis. Knee Surg Sports Traumatol Arthosc 19:528–535Google Scholar